Funding for this research was provided by:
France Recherche Nord & Sud Sida-HIV Hépatites (Coordinated Action no. 7 (ACT7))
Centre Hospitalier Universitaire de Bordeaux (FR) through the COREVIH Aquitaine, (Inserm (U1219))
Received: 13 August 2019
Accepted: 5 November 2020
First Online: 16 November 2020
Ethics approval and consent to participate
: Participants provided written informed consent and the study is conducted in compliance with the Helsinki Declaration.
: Dr. Bonnet reports non-financial support from Gilead, Janssen, ViiV healthcare, and MSD, personal fees from Gilead, Janssen, ViiV healthcare, and MSD, outside the submitted work; Dr. Cazanave reports personal fees and non-financial support from Gilead, ViiV Healthcare, and MSD, outside the submitted work; All other authors report nothing to disclose.